Trademark: ALLOVIR 2003050
Word
ALLOVIR
ID
2003050
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
12 April 2019
Registration Date
12 April 2019
Renewal Date
12 April 2029

Owner(s)
Service
KINGS PATENT & TRADE MARKS ATTORNEYS PTY LTD

Goods and Services:
Class 5:
Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of a variety of human and animal diseases and disorders, including viral-infections and viral-mediated diseases and disorders; anti-infectives; antivirals; anti-inflammatories; antibacterial pharmaceuticals; vaccines, including vaccines against pneumococcal infections; antifungal preparations; anti-cancer preparations; cardiovascular pharmaceuticals; biological preparations for the treatment of cancer and acute and chronic devastating diseases and conditions beyond cancer; biological preparations for the treatment of cancer; medical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions beyond cancer; medicinal preparations for the treatment of infectious diseases and for use in oncology; mixed biological preparations for the prevention and treatment of infectious diseases; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of ocular diseases and disorders, for the treatment bacteria-based diseases, and for the treatment of diabetes; pharmaceutical preparations for use in haematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorder; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer and acute and chronic devastating diseases and conditions beyond cancer; pharmaceutical preparations for the prevention and treatment of skin diseases; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumours; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; therapeutic pharmaceuticals for the treatment of cancer and acute and chronic devastating diseases and conditions beyond cancer; and cell therapy products for use in restoring, modulating and enhancing a patients immune system for the treatment of a variety of human diseases and disorders, including viral-infections and viral-mediated diseases and disorders